| Outcome Measures: |
Primary: Response rate (percentage of patients who meet the target HbA1c ≤7%) at week 24 (6 months) after adding insulin therapy, week 24 (6 months) | Secondary: Percentage of patients with HbA1c ≤7%, week 12 (3 months)|Change from baseline in HbA1c, week 12 (3 months), week 24 (6 months)|Percentage of patients with HbA1c ≤6.5%, week 12 (3 months), week 24 (6 months)|Change from baseline in Fasting Plasma glucose (FPG), 2hr-Postprandial Plasma Glucose, week 12 (3 months), week 24 (6 months)|Total daily insulin dose, week 24 (6 months)|Fasting blood glucose (FBG) values, During 3 consecutive days before baseline, week 12, Week 24|7-point Self Monitoring of Blood Glucose, During 2 days within 7 days before baseline, week 12, week 24|Weight change from baseline, week 24 (6 months)|Number of Patients with Hypoglycemic Events, up to 6 months|Number of Patients with Adverse Events, up to 6 months
|
